Sohaib Haseeb
Queen's University
55 Papers
86 Citations
Sohaib Haseeb is an academic researcher from Queen's University. The author has contributed to research in topics: Medicine & Atrial fibrillation. The author has an hindex of 9, co-authored 53 publications. Previous affiliations of Sohaib Haseeb include James Cook University.
Chat about Author
Papers
Wine and Cardiovascular Health: A Comprehensive Review
TL;DR: The composition of wine and the effects of constituent polyphenols on chronic cardiovascular diseases are described and a consensus has not been reached as to whether light-to-moderate intake is cardioprotective.
185
New electrocardiographic score for the prediction of atrial fibrillation: The MVP ECG risk score (morphology-voltage-P-wave duration).
Bryce Alexander,Julia Milden,Bachar Hazim,Sohaib Haseeb,Antoni Bayes-Genis,Roberto Elosua,Manuel Martínez-Sellés,Cynthia Yeung,Wilma M. Hopman,Antoni Bayés de Luna,Adrian Baranchuk +10 more
TL;DR: An electrocardiographic risk score for new‐onset AF is developed and found to be of great value in order to stratify patients for increased monitoring and surveillance.
Value of electrocardiography in coronavirus disease 2019 (COVID-19).
Sohaib Haseeb,Enes Elvin Gul,Göksel Çinier,George Bazoukis,Jesús Álvarez-García,Sebastian Garcia-Zamora,Sharen Lee,Cynthia Yeung,Tong Liu,Gary Tse,Adrian Baranchuk +10 more
TL;DR: The role of the ECG is reviewed in the identification of cardiac involvement in COVID-19, highlighting relevant clinical implications and wide disponibility, low cost, and the possibility of remote evaluation.
68
Are implanted electronic devices hackable
TL;DR: The actions taken by all the involved stakeholders in response to the disclosure of potential vulnerabilities in medical devices are outlined and the positions of major societies in response are summarized.
30
Pacemaker Cybersecurity: Local Experience With a Firmware Upgrade.
Adrian Baranchuk,Bryce Alexander,Debra Campbell,Sohaib Haseeb,Damian P. Redfearn,Christopher S. Simpson,Ben Glover +6 more
TL;DR: In response to these events, Abbott released a firmware upgrade with enhanced cybersecurity, which was followed by a safety communication issued by the FDA in January of 2017 describing the vulnerabilities and informing the public of a software patch.
24